Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faropenem in adult community-acquired bacterial pneumonia
NCT01886053Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2011
- Primary completion
- Jul 2012
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of faropenem in community-acquired bacterial pneumonia (CAP), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Apr 2011; status: completed.
02
Drugs
faropenem
03
Conditions
community-acquired bacterial pneumonia (CAP)
Beyond the preview
Go deeper on NCT01886053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01886053.